Greg Mattingly, M.D.

Greg Mattingly, M.D., is an associate clinical professor at Washington University School of Medicine. He serves on the scientific advisory board at Revibe and has been a principal investigator in trials for Akilli, Lumos Labs, and other digital therapeutics. He is also a founding partner of St. Charles Psychiatric Associates and serves on the board of directors for the American Professional Society of ADHD and Related Disorders.

ADDitude’s Editorial and Medical Review Process

ADDitude is dedicated to publishing quality content that adheres to the highest scientific and editorial standards. Created by qualified writers and medical professionals, our content is fact-checked and reviewed by members of the ADDitude Medical Advisory Panel, including leading clinical practitioners and researchers within the field of ADHD. The ADDitude team adheres to strict editorial standards and journalistic principles. Health information and guidance is thoroughly researched, and sources are vetted to ensure recency, authority, and credibility.

ADDitude editors regularly revisit and update existing content for accuracy and reliability, often in coordination with ADDitude’s Medical Advisory Panel and according to the ADDitude Editorial Process.